Microtubule-associated protein tau gene: A risk factor in human neurodegenerative diseases

Neurobiology of Disease

Volumn 15, Issue 3, 2004, Pages 449-460

  Schraen Maschke, Susanna ^a   Dhaenens, Claire Marie ^a   Delacourte, André ^a   Sablonnière, Bernard ^a  

^a INSERM   (France)

Author keywords

Haplotypes; Neurodegenerative diseases; Polymorphisms; Tau gene

Indexed keywords

TAU PROTEIN;

CELL ORGANELLE; CHROMOSOME 17; CHROMOSOME ABERRATION; DEGENERATIVE DISEASE; DENDRITE; FRONTOTEMPORAL DEMENTIA; GENE; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; MICROTUBULE; MOLECULAR GENETICS; NERVE FIBER; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMERIZATION; PROTEIN POLYMORPHISM; REVIEW; RISK FACTOR; TAU GENE; TAUOPATHY;

BASE SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; NEURODEGENERATIVE DISEASES; POLYMORPHISM, GENETIC; RISK FACTORS; TAU PROTEINS;

EID: 1842419456     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2003.12.009     Document Type: Review

References (113)

1. Andreadis A., Brown W.M., Kosik K.S. Structure and novel exons of the human tau gene. Biochemistry. 31:1992;10626-10633.
2. Andreadis A., Wagner B.K., Broderick J.A., Kosik K.S. A tau promoter region without neuronal specificity. J. Neurochem. 66:1996;2257-2263.
3. Arnold S.E. Cellular and molecular pathology of the frontal dementias. Clark C.M., Trojanowski J.Q. Neurodegenerative Dementias: Clinical Features and Pathological Mechanisms. 2000;291-301 McGraw-Hill, New York.
4. Aronov S., Marx R., Ginzburg I. Identification of 3′UTR region implicated in tau mRNA stabilization in neuronal cells. J. Mol. Neurosci. 12:1999;131-145.
5. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E., Hutton M. Association of an extended tau haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8:1999;711-715.
6. Baker M., Graff-Radford D., Wavrant de Vrieze F., Graff-Radford N., Petersen R.C., Kokmen E., Boeve B., Myllykangas L., Polvikovski T., Sulkava R., Verkoniemmi A., Tienari P., Haltia M., Hardy J., Hutton M., Perez-Tur J. No association between tau haplotype and Alzheimer's disease in population or clinic based series or in familial disease. Neurosci. Lett. 285:2000;147-149.
7. Bennett P., Bonifati V., Bonucelli U., Colosimo C., De Mari M., Fabbrini G., Marconi R., Meco G., Nicholl D., Stocchi F., Vanacore N., Vieregge P., Williams A.C. Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium. Neurology. 51:1998;982-985.
8. Buée L., Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration. FTDP-17 and Pick's disease. Brain Pathol. 9:1999;681-693.
9. Buée L., Bussière T., Buée-Scherrer V., Delacourte A., Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Rev. 33:2000;95-130.
10. Bullido M., Aldulo J., Frank A., Coria F., Avila J., Valdiviesio F. A polymorphism in the tau gene associated with risk for Alzheimer's disease. Neurosci. Lett. 278:2000;49-52.
11. Chambers C.B., Lee J.M., Troncoso J.C., Reich S., Muma N.A. Overexpression of four-repeat-tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease. Ann. Neurol. 46:1999;325-332.
12. Chartier-Harlin M.C., Parfitt M., Legrain S., Perez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V.et al. Apolipoprotein E epsilon 4 allele as a major risk factor for sporadic early and late-onset form of Alzheimer's disease: analysis of the 10q13.2 chromosomal region. Hum. Mol. Genet. 3:1994;569-574.
13. Clark L.N., Levy G., Tang M., Mejia-Santana H., Ciappa A., Tycko B., Cote L.J., Louis E.D., Mayeux R., Marder K. The saitohin Q7R polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts. Neurosci. Lett. 347:2003;17-20.
14. Cleveland D., Hwo S.Y., Kirschner M.W. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J. Mol. Biol. 116:1977;207-225.
15. Combarros O., Rodero L., Infante J., Palacio E., Liorca J., Fernandez-Viadero C., Pena N., Berciano J. Age-dependent association between the Q7R polymorphism in the Saitohin gene and sporadic Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 16:2003;132-135.
16. Conrad C., Andreadis A., Trojanowski J.Q., Dickson D.W., Kang D., Chen X., Wiederholt W., Hansen L., Masliah E., Thal L., Katzman R., Xia Y., Saitoh T. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann. Neurol. 41:1997;277-281.
17. Conrad C., Amano N., Andreadis A., Xia Y., Namekataf K., Oyama F., Ikeda K., Wakabayashi K., Takahashi H., Thal L.J., Katzman R., Shackelford D.A., Matsushita M., Masliah E., Sawa A. Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy. Neurosci. Lett. 250:1998;135-137.
18. Conrad C., Vianna C., Freeman M., Davies P. A polymorphic gene nested within an intron of the tau gene: implications for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 99:2002;7751-7756.
19. Cook L., Brayne C.E., Easton D., Evans J., Xuereb J., Cairns N.J., Rubinsztein D.C. No evidence for an association between saitohin Q7R polymorphism and Alzheimer's disease. Ann. Neurol. 52:2002;690-691.
20. Crawford F., Freeman M., Town T., Fallin D., Gold M., Duara R., Mullan M. No genetic association between polymorphisms in the tau gene and Alzheimer's disease in clinic or population based samples. Neurosci. Lett. 266:1999;193-196.
21. Daw E.W., Payami H., Nemens E.J., Nochlin D., Bird T.D., Schellenberg G.D., Wijsman E.M. The number of trait loci in late-onset Alzheimer disease. Am. J. Hum. Genet. 66:2000;196-204.
22. Delacourte A. The molecular parameters of tau pathology; tau as a killer and a witness. Adv. Exp. Med. Biol. 487:2001;5-19.
23. Delacourte A., Buée L. Tau pathology: a marker of neurodegenerative disorders. Curr. Opin. Neurol. 13:2000;371-376.
24. Delacourte A., Sergeant N., Wattez A., Gauvreau D., Robitaille Y. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation. Ann. Neurol. 43:1998;193-204.
25. Delacourte A., Sergeant N., Champain D., Wattez A., Maurage C.A., Lebert F., Pasquier F., David J.P. The biochemical spreading of tau and amyloid β-precursor protein pathologies in aging and sporadic Alzheimer's disease. Brain Aging. 1:2001;33-42.
26. de Silva R., Weiler M., Morris H.R., Martin E.R., Wood N.W., Lees A.J. Strong association of a novel tau promoter haplotype in progressive supranuclear palsy. Neurosci. Lett. 311:2001;145-148.
27. de Silva R., Hardy J., Crook J., Khan N., Graham E.A., Morris C.M., Wood N.W., Lees A.J. The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease. Neurosci. Lett. 330:2002;201-203.
28. de Silva R., Hope A., Pittman A., Weale M.E., Morris H.R., Wood N.W., Lees A.J. Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy. Neurology. 61:2003;407-409.
29. de Yebenes Y.G., Sarasa J.L., Daniel S.E., Lees A.J. Familial progressive supranuclear palsy: description of a pedigree and review of the literature. Brain. 118:1995;1095-1103.
30. Di Maria E., Tabaton M., Vigo T., Abbruzzese G., Bellone E., Donati C., Frasson E., Marchese R., Montagna P., Munoz D.G., Pramstaler P.P., Zanusso G., Ajmar F., Mandich P. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann. Neurol. 47:2000;374-377.
31. Ebneth A., Godemann R., Stamer K., Illenberg S., Trinczek B., Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J. Cell Biol. 143:1998;777-794.
32. Esclaire F., Terro F., Yardin C., Hugon J. Neuronal apoptosis is associated with decrease in tau mRNA expression. NeuroReport. 9:1998;1173-1177.
33. Ezquerra M., Pastor P., Valldeoriola F., Molinuevo J., Blesa R., Tolosa E., Oliva R. Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans. Neurosci. Lett. 275:1999;183-186.
34. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.N. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease Meta Analysis Consortium. JAMA. 278:1997;1349-1356.
35. Farrer M., Skipper L., Berg M., Bisceglio G., Hanson M., Hardy J., Adam A., Gwinn-Hardy K., Aasly J. The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population. Neurosci. Lett. 322:2002;83-86.
36. Flament S., Delacourte A., Verny M., Hauw J.J., Javoy-Agid F. Abnormal tau protein in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol. 81:1991;591-596.
37. Forman M.S., Lee V.M., Trojanowski J.Q. New insights into genetic and molecular mechanisms of brain degeneration in tauopathies. J. Chem. Neuroanat. 20:2000;225-244.
38. Goedert M., Spillantini M.G. Tau gene mutations and neurodegeneration. Biochem. Soc. Symp. 67:2001;59-71.
39. Goedert M., Wischik C., Crowther R.A., Walker J.E. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. U. S. A. 85:1988;4051-4055.
40. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 3:1989;519-526.
41. Goedert M., Spillantini M.G., Crowther R.A. Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. Proc. Natl. Acad. Sci. U. S. A. 89:1992;1983-1987.
42. Golbe L.I. Progressive supranuclear palsy. Stern M.B., Koller W.C. Parkinsonian Syndromes. 1993;227-247 Dekker, New York.
43. Golbe L.I., Lazzarini A.M., Spychala J.R., Johnson W.G., Stenroos E.S., Mark M.H., Sage J.I. The tau A0 allele in Parkinson's disease. Mov. Disord. 16:2001;442-447.
44. Green E.K., Thaker U., McDonagh A.M., Iwatsubo T., Lambert J.C., Chartier-Harlin M.C., Harris J.M., Pickering-Brown S.M., Lendon C.L., Mann D.M. A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain. Neurosci. Lett. 324:2002;113-118.
45. Gu Y., Oyama F., Ihara Y. Tau is widely expressed in rat tissues. J. Neurochem. 67:1996;1235-1244.
46. Harada A., Oguchi K., Okabe S., Kuno J., Terada S., Ohshima T., Sato-Yoshikate R., Takei Y., Noda T., Hirokawa N. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature. 369:1994;488-491.
47. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
48. Hauw J.J., Daniel S.E., Dickson D., Horoupian D.S., Jellinger K., Lantos P., McKee A., Tabaton M., Litvan I. Preliminary NINDS neuropathological criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 44:1994;2015-2019.
49. Heicklen-Klein A., Ginzburg I. Tau promoter confers neuronal specificity and binds Sp1 and AP-2. J. Neurochem. 75:2000;1408-1418.
50. Higgins J.J., Litvan I., Pho L.T., Li W., Nee L.E. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the α-synuclein gene. Neurology. 50:1998;270-273.
51. Higgins J.J., Adler R.L., Loveless J.M. Mutational analysis of the tau gene in progressive supranuclear palsy. Neurology. 53:1999;1421-1424.
52. Higgins J.J., Golbe L.I., De Biase A., Jankovic J., Factor S.A., Adler R.L. An extended 5′-tau susceptibility haplotype in progressive supranuclear palsy. Neurology. 55:2000;1364-1367.
53. Himmler A., Drechsel D., Kirschner M.W., Martin D.W. Jr. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol. Cell. Biol. 9:1989;1381-1388.
54. Houlden H., Baker M., Adamson J., Grover A., Waring S., Dickson D., Lynch T., Boeve B., Petersen R.C., Pickering-Brown S., Owen F., Neary D., Craufurd D., Snowden J., Mann D., Hutton M. Frequency of tau mutations in three series of non-Alzheimer's neurodegenerative dementias. Ann. Neurol. 46:1999;243-248.
55. Houlden H., Baker M., Morris H.R., MacDonald N., Pickering-Brown S., Owen F. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 56:2001;1702-1706.
56. Hughes A., Mann D., Pickering-Brown S. Tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Exp. Neurol. 181:2003;12-16.
57. Hutton M. Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms. Neurology. 56:2001;S21-S25.
58. Hutton M., Lendon C., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Heutink P.et al. Association of missense and 5′ splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393:1998;702-705.
59. Ingelson M., Fabre S., Lilius L., Andersen C., Viitanen M., Almkvist O., Wahlund L.O., Lannfelt L. Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon 4. NeuroReport. 12:2001;905-909.
60. Ingram E.M., Spillantini M.G. Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol. Med. 8:2002;555-562.
61. Jensen P.H., Hager H., Nielsen M.S., Hojrup P., Gliemann J., Jakes R. Alpha-synuclein binds to tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. J. Biol. Chem. 274:1999;25481-25489.
62. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene causes autosomal recessive juvenile parkinsonism. Nature. 392:1998;605-608.
63. Kwon J.M., Nowotny P., Shah P.K., Chakraverty S., Norton J., Morris J.C., Goate A.M. Tau polymorphisms are not associated with Alzheimer's disease. Neurosci. Lett. 284:2000;77-80.
64. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24:2001;1121-1159.
65. Lennox G., Lowe J., Morrell K., Landon M., Mayer R.J. Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of Lewy body disease. J. Neurol., Neurosurg. Psychiatry. 52:1989;67-71.
66. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M., Jonnalagada S., Chernova T., Dehejia A., Lavedan C., Gasser T., Steinbach P.J., Wilkins K.D., Polymeropoulos M.H. The ubiquitin pathway in Parkinson's disease. Nature. 395:1998;451-452.
67. Lilius L., Froelich-Fabre S., Basun H., Forsell C., Axelman K., Mattila K., Andreadis A., Viitanen M., Winblad B., Fratiglioni L., Lannfelt L. Tau gene polymorphisms and apolipoprotein E epsilon 4 may interact to increase risk for Alzheimer's disease. Neurosci. Lett. 277:1999;29-32.
68. Liu W.K., Le T.V., Adamson J., Baker M., Cookson N., Hardy J., Hutton M., Yen S.H., Dickson D.W. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Ann. Neurol. 50:2001;494-502.
69. Maillot C., Sergeant N., Bussière T., Caillet-Boudin M., Delacourte A., Buée L. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. FEBS Lett. 433:1998;201-204.
70. Maraganore D.M., Hernandez D.G., Singleton A.B., Farrer M.J., McDonnell S.K., Hutton M.L., Hardy J.A., Rocca W.A. Case-control study of the extended tau gene haplotype in Parkinson's disease. Ann. Neurol. 50:2001;658-661.
71. Martin E.R., Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Lyons K., Pahwa R., Stern M.B., Colcher A., Hiner B.C., Jankovic J., Ondo W.G., Allen F.H., Goetz C.G., Small G.W., Masterman D., Mastaglia F., Laing N.G., Stajich J.M., Ribble R.C., Booze M.W., Rogala A., Hauser M.A., Zhang F., Gibson R.A., Middleton L., Roses A.D., Haines J.L., Scott B.L., Perick-Vance M.A., Vance J.M. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA. 286:2001;2245-2250.
72. Maurage C.A., Sergeant N., Schraen-Maschke S., Lebert F., Ruchoux M.M., Sablonnière B., Pasquier F., Delacourte A. Diffuse form of argyrophilic grain disease: a new variant of 4-repeat tauopathy different from limbic argyrophilic grain disease. Acta Neuropathol. 106:2003;575-583.
73. Morris H.R., Janssen J.C., Bandmann O., Daniel S.E., Rossor M.N., Lees A.J., Wood N.W. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J. Neurol., Neurosurg. Psychiatry. 66:1999;665-667.
74. Morris H.R., Khan M., Janssen J., Brown J., Perez-Tur J., Baker M., Ozansoy M., Hardy J., Hutton M., Wood N.W., Lees A.J., Revesz T., Lantos P., Rossor M.N. The genetic and pathological classification of familial frontotemporal dementia. Arch. Neurol. 58:2001;1813-1816.
75. Morris H.R., Baker M., Yasojima K., Houlden H., Khan M.N., Wood N.W., Hardy J., Grossman M., Trojanowski J.Q., Revesz T., Bigio E.H., Bergeron C., Janssen J.C., McGeer P.L., Rossor M.N., Lees A.J., Lantos P.L., Hutton M. Analysis of tau haplotypes in Pick's disease. Neurology. 59:2002;443-445.
76. Neve R.L., Harris P., Kosik K.S., Kurnit D.M., Donlon T.A. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res. 387:1986;271-280.
77. Okuizumi K., Takano H., Seki K., Onishi Y., Horikawa Y., Tsuji S. Genetic polymorphisms of the tau gene and neurodegenerative diseases with tau pathology among Japanese. Ann. Neurol. 44:1998;707.
78. Oliva R., Tolosa E., Ezquerra M., Molinuevo J.L., Valldeoriola F., Burguera J., Calopa M., Villa M., Ballesta F. Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. Arch. Neurol. 55:1998;1122-1124.
79. Oliveira S.A., Martin E.R., Scott W.K., Nicodemus K.K., Small G.W., Schmechel D.E., Doraiswamy P.M., Roses A.D., Saunders A.M., Gilbert J.R., Haines J.L., Vance J.M., Pericak-Vance M.A. The Q7R Saitohin gene polymorphism is not associated with Alzheimer disease. Neurosci. Lett. 347:2003;143-146.
80. Panegyres P., Zafiris-Toufexis K. Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders. Eur. J. Neurol. 9:2002;485-489.
81. Pastor P., Ezquerra M., Munoz E., Marti M.J., Blesa R., Tolosa E., Oliva R. Significant association between the tau gene A0/A0 genotype and Parkinson's disease. Ann. Neurol. 47:2000;242-245.
82. Peplonska B., Zekanowski C., Religa D., Czyzewski K., Styczynska M., Pfeffer A., Gabryelewicz T., Golebiowski M., Luczywek E., Wasiak B., Barczak A., Chodakowski A., Barcikowska M., Kuznicki J. Strong association between Saitohin gene polymorphism and tau haplotype in the Polish population. Neurosci. Lett. 348:2003;163-166.
83. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
84. Poorkaj P., Grossman M., Steinbart E., Payami H., Sadovnick A., Nochlin D., Tabira T., Trojanowski J.Q., Borson S., Galasko D., Reich S., Quinn B., Schellenberg G., Bird T.D. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch. Neurol. 58:2001;383-387.
85. Poorkaj P., Kas A., D'Souza I., Zhou Y., Pham Q., Stone M., Olson M., Schellenberg G.D. A genomic sequence analysis of the mouse and human microtubule-associated protein tau. Mamm. Genome. 12:2001;700-712.
86. Poorkaj P., Tsuang D., Wijsman E., Steinbart E., Garutto R., Craig U., Chapman N.H., Anderson L., Bird T.D., Plato C.C., Perl D.P., Weiderholt W., Galasko D., Schellenberg G.D. Tau as a susceptibility gene for amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam. Arch. Neurol. 58:2001;1871-1878.
87. Roks G., Dermaut B., Heutink P., Julliams A., Backhovens H., Van de Broeck M., Sterneels S., Hofman A., van Broeckhoven C., van Duijn C.M., Cruts M. Mutation screening of the tau gene in patients with early-onset Alzheimer's disease. Neurosci. Lett. 277:1999;137-139.
88. Roses A.D., Devlin B., Coneally P.M. Measuring the genetic contribution of APOE in late-onset Alzheimer's disease. Am. J. Hum. Genet. Suppl. 57:1995;A202.
89. Rosso S.M., van Swieten J.C. New developments in frontotemporal dementia and Parkinsonism linked to chromosome 17. Curr. Opin. Neurol. 4:2002;423-428.
90. Russ C., Lovestone S., Baker M., Pickering-Brown S.M., Andersen P.M., Furlong R., Mann D., Powell J.F. The extended haplotype of the microtubule associated protein tau gene is not associated with Pick's disease. Neurosci. Lett. 299:2001;156-158.
91. Russ C., Powell J.F., Zhao J., Baker M., Hutton M., Crawford F., Mullan M., Roks G., Cruts M., Lovestone S. The microtubule-associated protein tau gene and Alzheimer's disease. An association study and meta-analysis. Neurosci. Lett. 314:2001;92-96.
92. Sadot E., Marx R., Barg J., Behar L., Ginzburg I. Complete sequence of 3′-untranslated region of tau from rat central nervous system. Implications for mRNA heterogeneity. J. Mol. Biol. 241:1994;325-331.
93. Schmidt M., Huang R., Martin J.A., Henley J., Mawal-Dewan M., Hurtig H.I., Lee V.M., Trojanowski J.Q. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHF tau. J. Neuropathol. Exp. Neurol. 55:1996;534-539.
94. Scott W.K., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Lyons K., Pahwa R., Stern M.B., Colcher A., Hiner B.C., Jankovic J., Ondo W.G., Allen F.J., Goetz C.G., Small G.W., Masterman D., Mastaglia F., Laing N.G., Stajich J.M., Slotterbeck B., Booze M.W., Ribble R.C., Rampersaud E., West S.G., Gibson R.A., Middleton L.T., Roses A., Haines J.L., Scott B.L., Vance J.M., Pericak-Vance M.A. Complete genomic screen in Parkinson's disease: evidence for multiple genes. JAMA. 286:2001;2239-2244.
95. Sergeant N., Wattez A., Delacourte A. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively ≪exon 10≫ isoforms. J. Neurochem. 72:1999;1243-1249.
96. Shimura H., Hattori N., Kubo S., Yoshikawa M., Kitada T., Matsumine H., Asakawa S., Minoshima S., Yamamura Y., Shimizu N., Mizuno Y. Immunohistochemical and subcellular localization of parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann. Neurol. 45:1999;668-672.
97. Short R.A., Graff-Radford N.R., Adamson J., Baker M., Hutton M. Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Arch. Neurol. 59:2002;611-615.
98. Sobrido M.J., Abu-Khalil A., Weintraub S., Johnson N., Quinn B., Cummings J.L., Mesulam M.M., Geschwind D.H. Possible association of the tau H1/H1 genotype with primary progressive aphasia. Neurology. 60:2002;698-702.
99. Sobrido M.J., Miller B.L., Havlioglu N., Zhukareva V., Jiang Z., Nasreddine Z.S., Lee V.M., Chow T.W., Wilhemsen K.C., Cummings J.L., Wu J.Y., Geshwind D.H. Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia. Arch. Neurol. 60:2003;698-702.
100. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J., Jakes R., Goedert M. α-Synuclein in Lewy bodies. Nature. 388:1997;839-840.
101. Stamer K., Vogel R., Thies E., Mandelkow E., Mandelkow E.M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156:2002;1051-1063.
102. Streffer J.R., Papassotiropoulos A., Kurosinski P., Signorell A., Wollmer M.A., Tsolaki M., Iakovidou V., Horndli F., Bosset J., Gotz J., Nitsch R.M., Hock C. Saitohin gene is not associated with Alzheimer's disease. J. Neurol., Neurosurg. Psychiatry. 74:2003;362-363.
103. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 90:1993;1977-1981.
104. Takanashi M., Mori H., Arima K., Mizuno Y., Hattori N. Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration. Mol. Brain Res. 104:2002;210-219.
105. van Swieten J.C., Stevens M., Rosso S.M., Rizzu P., Joosse M., de Koning I., Kamphorst W., Ravid R., Spillantini M.G., Niermeijer A., Heutink P. Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann. Neurol. 46:1999;617-626.
106. Vermersch P., Robitaille Y., Bernier L., Wattez A., Gauvreau D., Delacourte A. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement. Acta Neuropathol. 87:1994;572-577.
107. Verpillat P., Camuzat A., Hannequin D., Thomas-Anterion C., Puel M., Belliard S., Dubois B., Didic M., Michel B.F., Lacomblez L., Moreaud O., Sellal F., Golfier V., Campion D., Clerget-Darpoux F., Brice A. Association between the extended tau haplotype and frontotemporal dementia. Arch. Neurol. 59:2002;935-939.
108. Verpillat P., Ricard S., Hannequin D., Dubois B., Bou J., Camuzat A., Pradier L., Frebourg T., Brice A., Clergetr-Darpoux F., Deleuze J.F., Campion D. French Study Group on Alzheimer's disease and Frontotemporal dementia. Is the saitohin gene involved in neurodegenerative diseases? Ann. Neurol. 52:2002;829-832.
109. Wang Y., Loomis P., Zinkowski R., Binder L.I. A novel tau transcript in cultured human neuroblastoma cells expressing nuclear tau. J. Cell Biol. 121:1993;257-267.
110. Weingarten M.D., Lockwood A.H., Hwo S.Y., Kirschner M.W. A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. U. S. A. 72:1975;1858-1862.
111. Wilhelmsen K.C., Lynch T., Pavlou E., Higgins M., Nygaard T.G. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am. J. Hum. Genet. 55:1994;1159-1165.
112. Wisniewski T., Golabek A., Matsubara E., Ghiso J., Frangione B. Apolipoprotein E: biding to soluble Alzheimer's beta-amyloid. Biochem. Biophys. Res. Commun. 192:1993;359-365.
113. Zhukareva V., Vogelberg-Ragaglia V., van Deerlin V., Brice J., Shuck T., Grossman M., Clark C.M., Arnold S., Masliah E., Galasko D., Trojanowski J.Q., Lee V.M. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann. Neurol. 49:2001;165-175.